We also explored the effect of ASB3 on the GBM clinical features, and the results showed that the expression of ASB3 in GBM patients with IDH mutations was higher than those with IDH wild-type, while the IDH mutations were considered to be crucial for better determining the prognosis (31). This evidence concerns the gene ASB3 and glioblastoma.